STIFEL FINANCIAL CORP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$1,179,208
+36.9%
12,593
+30.5%
0.00%
+100.0%
Q2 2023$861,446
-12.4%
9,652
+5.3%
0.00%0.0%
Q1 2023$982,994
-14.1%
9,168
-2.2%
0.00%
-50.0%
Q4 2022$1,144,728
+26.2%
9,373
+6.7%
0.00%
+100.0%
Q3 2022$907,000
+17.6%
8,787
+6.0%
0.00%0.0%
Q2 2022$771,000
-20.7%
8,290
+0.1%
0.00%0.0%
Q1 2022$972,000
-14.4%
8,278
-2.0%
0.00%
-50.0%
Q4 2021$1,136,000
-4.9%
8,443
+12.7%
0.00%0.0%
Q3 2021$1,194,000
+39.0%
7,489
+14.7%
0.00%
+100.0%
Q2 2021$859,000
+0.7%
6,527
-1.3%
0.00%0.0%
Q1 2021$853,000
-23.2%
6,616
-0.6%
0.00%
-50.0%
Q4 2020$1,110,000
+7.1%
6,658
-0.8%
0.00%0.0%
Q3 2020$1,036,000
+8.7%
6,714
+4.2%
0.00%0.0%
Q2 2020$953,000
+25.1%
6,446
-4.9%
0.00%0.0%
Q1 2020$762,000
-18.3%
6,781
+1.0%
0.00%0.0%
Q4 2019$933,000
+129.2%
6,712
+59.7%
0.00%
+100.0%
Q3 2019$407,000
+38.0%
4,203
+62.5%
0.00%0.0%
Q2 2019$295,000
-8.7%
2,587
-5.4%
0.00%0.0%
Q1 2019$323,0002,7340.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders